HYGIEIA

Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy. It works by guiding users to adjust their insulin doses based on changing blood glucose patterns every few days rather than three or four times annually. Its insulin guidance device replaces a patient's existing glucose meter and provides individually tailored insulin dosage recommendations between physician visits to result in the patients monitoring their diabetes levels digitally and also provides personalized adjustments to enhance and simplify it, maximizing insulin effectiveness and resulting in improved glycemic control.

HYGIEIA headquartered in United States, North America, operates in the Biotechnology, Health Care, Diabetes sector. The company focuses on Biotechnology and has secured $5.9B in funding across 168 round(s). With a team of 11-50 employees, HYGIEIA is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - HYGIEIA, raised $145.0K. Discover more about their projects, partnerships, and impact on our platform.